A new facility opened in Wallingford Saturday afternoon that treats mental health conditions with low doses of Ketamine.
Johnson & Johnson reported that Spravato treated over 100,000 patients in 77 countries worldwide, including roughly 80,000 in ...
Spravato, a newly FDA-approved nasal spray, offers hope for individuals with treatment-resistant depression, a condition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback